P6-36 Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL) : 2. Chemical speciation of arsenic metabolites in serum and urine(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedi
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-10-29
著者
-
Hirata Miyuki
Hygiene Graduate School Of Medical Sciences Kyushu University
-
KAISE Toshikazu
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
FUKAI Yasuomi
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
OHTA Shin
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
UENO Mayumi
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
KOBAYASHI Hikaru
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
SAITOH Hiroshi
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
KINOSHITA Kenji
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
-
HIRATA Miyuki
Hygiene, Graduate School of Medical Sci., Kyushu Univ.
関連論文
- Clinical Pharmacokinetic Study of Arsenic Trioxide in an Acute Promyelocytic Leukemia (APL) Patient : Speciation of Arsenic Metabolites in Serum and Urine(Pharmacology)
- P6-36 Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL) : 2. Chemical speciation of arsenic metabolites in serum and urine(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedi
- P6-35 Efficacy and pharmacokinetics of arsenic trioxide for treatment of acute promyelocytic leukemia(APL) : 1. Efficacy for APL of Arsenic trioxide(ATO)(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annu